KAHR Bio is a biotechnology company developing immunotherapies, particularly engineered fusion-protein therapies intended to activate or modulate immune responses against cancer.…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see KAHR Bio →Already a subscriber? Sign in
Xcout Intel tracks KAHR Bio continuously — this profile deepens as new filings, funding, people and hiring data arrive.